Context Therapeutics CNTX
NASDAQ CNTX
$0.17 +0.00 (+0.00%)
At close: Nov 19, 2026 · 4:00 PM EST

Context Therapeutics (CNTX) Share-based Compensation (2020 - 2026)

Updated

Context Therapeutics' Share-based Compensation came in at $456,913 for Q3 2026, up 41.4% from $323,081 a year earlier but down 13.5% from the prior quarter.

Analysis

Context Therapeutics (CNTX) Share-based Compensation (2020 - 2026) Analysis & Trends

Over the trailing twelve months to Sep 30, 2026, Context Therapeutics reported Share-based Compensation of $1.72 million, up 38.9% year-over-year; for FY2025, it was $1.33 million, up 58.1% from FY2024.

  • Share-based Compensation carries a five-year compound annual growth rate of 43.4% (FY2020 to FY2025).
  • Going back by year, Share-based Compensation was $841,867 in FY2024 (-21.8%), $1.08 million in FY2023 (+10.3%), $976,440 in FY2022 (+91.1%) and $511,079 in FY2021 (+133.1%).
  • The five-year range for quarterly Share-based Compensation is $157,037 (Q2 2024) to $528,102 (Q2 2026).
  • Year-over-year, Share-based Compensation has increased for seven consecutive quarters, with growth averaging 46.1% over the last eight quarters.
  • The fastest year-over-year change in Share-based Compensation over five years came in Q1 2022 (growth of 742.5%), and the weakest in Q2 2024 (a decline of 44.5%).
  • Business Quant data shows CNTX's Share-based Compensation at $528,102 (Q2 2026), $409,220 (Q1 2026) and $325,168 (Q4 2025) in the three quarters before Q3 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 PetVivo Holdings 3,096.39 Bn 3,096.39 Bn 196,075.00 372,681.00
2 Eli Lilly 1,202.70 Bn 1,176.32 Bn 20.46 Bn 200.00 Mn
3 Johnson & Johnson 649.77 Bn 569.63 Bn 17.30 Bn 357.00 Mn
4 AbbVie 507.00 Bn 475.00 Bn 13.12 Bn 160.00 Mn
5 Merck 329.70 Bn 292.64 Bn 13.19 Bn 369.00 Mn
6 Novartis Ag 291.91 Bn 265.14 Bn - -
7 Amgen 236.26 Bn 187.91 Bn 7.58 Bn 128.00 Mn
8 Gilead Sciences 207.15 Bn 182.26 Bn 6.73 Bn 234.00 Mn
9 Gsk 193.54 Bn 176.38 Bn - -
10 Context Therapeutics 15.24 Mn -182.70 Mn - 456,913.00
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 456,913.00
Jun 30, 2026 528,102.00
Mar 31, 2026 409,220.00
Dec 31, 2025 325,168.00
Sep 30, 2025 323,081.00
Jun 30, 2025 389,114.00
Mar 31, 2025 293,717.00
Dec 31, 2024 231,821.00
Sep 30, 2024 213,002.00
Jun 30, 2024 157,037.00
Mar 31, 2024 240,007.00
Dec 31, 2023 256,051.00
Sep 30, 2023 254,949.00
Jun 30, 2023 283,103.00
Mar 31, 2023 282,762.00
Dec 31, 2022 243,637.00
Sep 30, 2022 276,521.00
Jun 30, 2022 241,324.00
Mar 31, 2022 214,958.00
Dec 31, 2021 204,380.00
API Access

Context Therapeutics Share-based Compensation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation&ticker=CNTX&period=max&api_key=YOUR_API_KEY